Product Name :
Recombinant human tissue-type plasminogen activator derivative (Shanghai Fudan-Zhangjiang/Shandong Ahua)
Search keywords :
Reteplase
drugId :
null
Target Vo:
Plasminogen
Target Vo Short Name :
PLG
Moa_Name:
Plasminogen stimulants
First Approval Country :
Mainland China
First Approval Date Filter:
2007
Origin Company_Name :
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Active Company_Name :
China Resources Angde Biotech Pharma Co Ltd
Active Indication_Name:
Myocardial Infarction
In Active Indication_Name:
Termination Status :
China Termination Status :
Highest Status:
Approved
China Highest Status:
Approved
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
p-RIPK1(S166) Antibody (YA1284) manufacturer
Trastuzumab emtansine (solution) EGFR
ZO-1/TJP1 Antibody: ZO-1/TJP1 Antibody is an unconjugated, approximately 191 kDa, rabbit-derived, anti-ZO-1/TJP1 polyclonal antibody. ZO-1/TJP1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, pig, and predicted: mouse, rat, chicken, dog, cow, rabbit, guinea pig background without labeling.